Azenta shows strong organic growth, margin expansion, $1B+ asset value, rebounding sales multiples, and positive FY26 guidance. See why AZTA stock is a hold.

Azenta, Inc. (Nasdaq: AZTA) today announced that its Board of Directors has approved a share repurchase program under which ...

A major earnings reset and fresh fund interest could mark a turning point for this formerly high-flying life-sciences stock.

Shares of Azenta rose on Wednesday after the company's board of directors approved the repurchase of up to $250 million of common stock. Shares rose 5% to $37.23, though are down 20% year-to-date. The ...

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market ...

Health-care companies rose amid optimism about earnings growth in the sector. Shares of Danish obesity drug maker Novo Nordisk rose by 5.8%, recouping some recent losses. Rival Eli Lilly rose modestly ...

List today: BellRing Brands BRBR is a manufacturer and seller of nutrition products. The Zacks Consensus Estimate for its current year earnings has been revised almost 14.6% downward over the last 60 ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Interim data from Wave Life Sciences' INLIGHT trial showed promising results for WVE-007, an investigational treatment for obesity.

The Conejo Valley’s life science moment is here — driven by global leaders, emerging innovators, modern infrastructure, and a ...

Some of the elements used by living systems are far more abundant in Cassiopeia A than we thought, hinting that some parts of ...

A bab y died. Three young kids, hospitalized. And, allegedly, it all happened in the name of health. Experts previously told USA TODAY it's all the more crucial people understand how to distinguish ...